PURE Financial Facts

Loss from operations: -3.22M
Net loss: -2.48M
See Full Income Statement

Patents, net: 1.4M
Total liabilities: 1.52M
See Full Balance Sheet

Pure Bioscience (PURE) Earnings

  |   Expand Research on PURE
Next EPS Date N/A EPS Growth Rate -316.7% *Last Qtr.
Average EPS % Beat Rate N/A Revenue Growth Rate -57.2% *Last Qtr.
Average % Move 1-Wk after EPS N/A Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
12/12/12 Q113 -$0.25N/A N/A $110K$257K N/A 0% Details
6/13/12 Q312 -$0.04N/A N/A $207K$128M N/A 0% Details
3/16/12 Q212 -$0.05N/A N/A $221K$68K N/A 0% Details
12/15/11 Q112 -$0.06N/A N/A $257K$23K N/A 0% Details
10/31/11 Q411 -$0.05N/A N/A $244K$324K N/A 0% Details
6/13/11 Q311 -$0.05N/A N/A $128.4K$536.5K N/A -64.1% Details
3/17/11 Q211 -$0.07N/A N/A N/A$3.22B N/A -78.6% Details
12/15/10 Q111 -$0.06N/A N/A N/AN/A N/A -84.3% Details